[A new approach to vaccine development: anti-idiotypic vaccines].
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage* / Q000276:immunology; D000937:Antigen-Antibody Reactions; D004926:Escherichia coli / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D011008:Pneumococcal Infections / Q000276:immunology; D012552:Schistosomiasis / Q000276:immunology; D014352:Trypanosomiasis / Q000276:immunology; D014612:Vaccines / Q000032:analysis / Q000276:immunology
D000276:Adjuvants, Immunologic; D000888:Antibodies, Anti-Idiotypic; D006514:Hepatitis B Surface Antigens; D007130:Immunoglobulin Idiotypes; D014612:Vaccines
Approche nouvelle dans le développement de vaccins: les vaccins anti-idiotypiques.